UnitedHealth Group Stock Slips as Medicare Advantage Margins Remain in Focus

UnitedHealth Group's stock price has declined from its recent high as investors continue to scrutinize its Medicare Advantage margins. The company reported a medical cost ratio of 86.7 percent in Medicare-related operations, an improvement of 2.7 percentage points compared with the prior-year period.

This trend has been weighing on investor sentiment, with the stock slipping earlier in the week as part of a broader selloff in managed-care stocks tied to rising medical-cost pressure.

Despite this, UnitedHealth's recent earnings beat and valuation context remain supportive. The company posted earnings of $6.38 per share, beating the Zacks Consensus Estimate of $4.94 per share and delivering a positive earnings surprise of 29.15 percent for the period.

The stock has retreated from its recent highs but remains well above long-term support levels, with an average price target of $456.56 implying upside of roughly 16.7 percent from the latest closing levels.